Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 59 | SFEBES2018 | Next issue

Society for Endocrinology BES 2018

Glasgow, UK
19 Nov 2018 - 21 Nov 2018

Card image cap
The Society for Endocrinology BES will take place 19-21 Nov 2018 in Glasgow. Come and exchange knowledge, share experiences and strengthen collaborations across our global community of endocrinologists.

Oral Communications

Translational highlights

ea0059oc1.1 | Translational highlights | SFEBES2018

Resilient reproductive, bone and adrenal function in Expedition Ice Maiden, the first all-female, unassisted Antarctic crossing

Gifford Robert , O'Leary Thomas , Greeves Julie , Anderson Richard , Reynolds Rebecca , Woods David

Higher short-term exercise-associated reproductive, psychological and bone health-related outcomes have been reported in women than men, although the reasons for this are poorly understood. The first, all-female transantarctic expedition provided a unique opportunity to perform an observational study examining concurrent effects of extreme exercise on pertinent hormonal axes to reproductive dysfunction and associated pathology. Body composition was measured by dual-energy xray...

ea0059oc1.2 | Translational highlights | SFEBES2018

Vitamin D insufficiency and elevated vitamin D metabolite ratios (VMR) are associated with increased risk of injuries: Results from the british army lower limb injury prevention (ALLIP) study

Tang Jonathan , Jackson Sarah , Izard Rachel , Oliver Samuel , Piec Isabelle , Washbourne Christopher , Walsh Neil , Greeves Julie , Fraser William

Introduction: British Army recruits suffer from musculoskeletal injuries (MSI) during initial training. Up to 10% suffer skeletal stress fracture (SFx) resulting in lost training days and medical attrition. There is evidence to suggest that vitamin D deficiency is prevalent in the army. Our aim was to determine vitamin D metabolites (VDM) in recruits upon starting training, and health outcomes after a 14-week training programme.Methods: ...

ea0059oc1.3 | Translational highlights | SFEBES2018

Novel insights into the genetic architecture of thyroid disease

Taylor Peter , Anney Richard , Dayan Colin , Ludgate Marian , Rees Aled

Introduction: There has been a substantial increase in our knowledge of the genetic architecture of thyroid function, with numerous variants associated with TSH and/or FT4 levels. However, our knowledge of the genetic variants associated with thyroid disease is more limited.Methods: Data was obtained from the Neale laboratory† which provided a case-control study to identify single nucleotide polymorphisms associated with a diagnosis of hypothyroidi...

ea0059oc1.4 | Translational highlights | SFEBES2018

Whole genome sequence analysis establishes correct diagnosis for a syndromic form of hyperuricaemia

Stevenson Mark , Pagnamenta Alistair T , Reichart Silvia , Mennel Stefan , Philpott Charlotte , Lines Kate E , Gorvin Caroline M , Lhotta Karl , Taylor Jenny C , Thakker Rajesh V

Whole genome sequencing (WGS) has the potential to identify nearly all forms of genetic variation. In complex disorders with multiple manifestations WGS can establish a definitive diagnosis that may change clinical management (Stavropoulos et al. 2016 Genomic Med). Here, we report on the utility of WGS in establishing the correct diagnosis in a family with hyperuricaemia. Hyperuricaemia may occur as: part of a syndromic disorder (e.g. Lowe syndrome, renal col...

ea0059oc1.5 | Translational highlights | SFEBES2018

In vivo and ex vivo metabolomics in succinate dehydrogenase deficient tumorigenesis

Casey Ruth , Basetti Madhu , McLean Mary , Challis Ben , Gallagher Ferdia , Maher Eamonn

Mutations affecting the mitochondrial enzyme succinate dehydrogenase (SDH) are associated with a wide spectrum of tumours. SDH deficient tumours have a unique tumour metabolome due to the interruption of the citric acid cycle and accumulation of the ‘oncometabolite’ succinate, which drives tumourigenesis. Investigating the tumour metabolome of SDH deficient tumours has potential translational application. MRI spectroscopy (1H-MRS) was used for in vivo<...

ea0059oc1.6 | Translational highlights | SFEBES2018

Germline CYP2W1*6 and CYP2B6*6 polymorphisms as predicting markers of sensitivity to mitotane treatment in advanced adrenocortical carcinoma: a multicentric ENSAT study

Altieri Barbara , Herterich Sabine , Sbiera Silviu , Volante Marco , Francia Silvia De , Casa Silvia Della , Pontecorvi Alfredo , Quinkler Marcus , Kienitz Tina , Mannelli Massimo , Canu Letizia , Chortis Vasileios , Kaltsas Gregory , Kroiss Matthias , Terzolo Massimo , Fassnacht Martin , Ronchi Cristina L

Adrenocortical carcinoma (ACC) is a rare tumor with poor prognosis and the only approved drug for advanced disease is mitotane. The cytochromes P450 (CYP) 2W1 and 2B6 are proposed predicting markers of sensitivity to mitotane treatment. Aim of the study was to evaluate the relationship between CYP2W1 and/or CYP2B6 polymorphisms and response to mitotane in ACC.Methods: We performed a multicentric retrospective study including 182 ACC patients (F/M=121/61)...